Buy MBRX by Jun 16, 2028.

Company has been testing a revolutionary cancer treatment currently in FDA testing. It’s seen incredible success over every single stage of the approval process and is being sought after by physicians who are eagerly waiting to start administering it. Chances are very good that it will pass. If and when it does it will explode. Finances are fairly solid for this ticker as well. No major debts, good cash and assets. I’m stacking up on this and I think everyone …